HealthRx.com

Oral Micronized Progesterone HSA/FSA Eligibility and Submission Guide

Prescription access and medication affordability image for Oral Micronized Progesterone HSA/FSA Eligibility and Submission Guide
Clinical image for GoodRx Prescription Process: How It Works, What It Costs, and How It Compares Image: HealthRX.com custom Semrush quick-win image

At a glance

  • Eligibility status / HSA and FSA eligible (prescription required)
  • Brand name / Prometrium (Solvay Pharmaceuticals)
  • FDA approval year / 1998 (NDA 019781)
  • IRS authority / IRS Publication 502 covers prescription drugs for HSA/FSA
  • Generic availability / Yes, multiple ANDA-approved generics available
  • Typical brand retail price / $180, $280 per 30-day supply (100 mg nightly)
  • GoodRx / Blink lowest generic price / as low as $18, $35 per 30-day supply
  • Manufacturer savings program / Allergan/AbbVie Access360 copay card (check current eligibility)
  • Submission deadline / FSA claims typically due 90 days after plan year end; HSA has no deadline
  • Key IRS citation / IRS Publication 502, "Medical and Dental Expenses"

Is Oral Micronized Progesterone HSA or FSA Eligible?

Oral micronized progesterone qualifies as an eligible medical expense under both HSAs and FSAs provided a licensed clinician has written a prescription. The IRS defines eligible expenses in Publication 502, which includes prescription medications dispensed by a licensed pharmacist. Because progesterone requires a prescription under federal law, it meets that threshold automatically.

The IRS Rule That Governs This

IRS Publication 502 states: "You can include in medical expenses the amounts you pay for prescription drugs and insulin." The Consolidated Appropriations Act of 2020 expanded OTC eligibility beginning January 1, 2020, but prescription-required drugs like oral micronized progesterone were already covered well before that change. The FDA-approved labeling for progesterone (NDA 019781) confirms its prescription-only status, which you can verify on the FDA label database. [1]

What "Prescription Required" Means for Your Claim

Your HSA or FSA administrator may ask for one of three documents: the pharmacy receipt showing the Rx number, a copy of the prescription, or an Explanation of Benefits from your insurer. Keeping all three on file reduces the chance of a claim rejection. Telehealth prescriptions issued by state-licensed clinicians count the same as in-person prescriptions for HSA and FSA purposes. [2]

Compounded Progesterone: A Different Standard

Compounded progesterone is treated differently. The IRS allows HSA/FSA reimbursement for compounded medications only if they are prepared pursuant to a valid prescription at a licensed pharmacy. The compound must not be classified as a cosmetic. Most BHRT compounded progesterone creams or troches ordered via telemedicine for menopausal symptoms do qualify because the indication (hormone deficiency) is medical, but check with your plan administrator before assuming coverage. [3]


How to Pay for Oral Micronized Progesterone with Your HSA or FSA

Paying at the point of sale is the simplest route. Swipe your HSA or FSA debit card when the pharmacist rings up the prescription. The pharmacy's register system is coded to block ineligible items, but prescription drugs are always flagged as eligible, so the transaction should clear without issue.

Direct Swipe at the Pharmacy Counter

Most major pharmacy chains, including CVS, Walgreens, Rite Aid, and Costco, accept HSA and FSA cards directly. Bring the card linked to your account and ask the pharmacist to run it as credit. Keep the printed receipt; your plan administrator may audit the expense later. [4]

Manual Reimbursement Submission

If you already paid out of pocket, you can file a reimbursement claim. The standard process involves:

  1. Logging into your HSA or FSA administrator portal.
  2. Uploading the pharmacy receipt, which must show the drug name, date dispensed, Rx number, and amount paid.
  3. Submitting within your plan's window (FSA windows are typically 90 days after the plan year closes; HSA has no statutory deadline).

Online platforms such as Alegeus, HealthEquity, and WEX all accept digital uploads. The turnaround for most administrators is 3 to 7 business days. [5]

Mail-Order and Specialty Pharmacy Options

Specialty pharmacies and mail-order programs through insurers like CVS Caremark, Express Scripts, and OptumRx also accept HSA and FSA cards. Mail-order often provides a 90-day supply at the price of roughly 2.5 months' supply, reducing your effective cost per day. Confirm that your plan allows mail-order before enrolling. [6]


Understanding Why Oral Micronized Progesterone Is Prescribed

Before optimizing payment strategy, it helps to understand what the drug does. Oral micronized progesterone is FDA-approved for the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving conjugated estrogens, and as a secondary indication for secondary amenorrhea. [1]

Clinical Evidence Supporting Its Use in Menopause

The Menopause Society (formerly NAMS) 2023 position statement on hormone therapy notes that micronized progesterone has a more favorable risk profile than synthetic progestins for breast tissue and cardiovascular parameters, though data are still accumulating. [7] The KEEPS trial (Kronos Early Estrogen Prevention Study, N=727) compared oral conjugated equine estrogens plus oral micronized progesterone against transdermal estradiol and found no significant difference in the primary outcome of carotid intima-media thickness progression over 48 months. [8]

Dosing That Determines Your Monthly Supply

The FDA-approved dose for endometrial protection is 200 mg orally once daily at bedtime for 12 days per 28-day cycle, or 100 mg orally every night continuously when paired with daily estrogen. [1] The 12-day cyclical regimen uses 12 capsules per month; the continuous 100 mg nightly regimen uses 30 capsules per month. Those supply quantities directly determine how many capsules your HSA/FSA claim will cover each month.

Prometrium vs. Generic Micronized Progesterone

The brand Prometrium (originally manufactured by Solvay, now distributed by AbbVie) contains peanut oil as a carrier. Multiple generic versions approved under ANDA filings contain different carrier oils (sunflower, safflower) and may be suitable for patients with peanut allergies. All FDA-approved generics are bioequivalent to Prometrium based on standard pharmacokinetic studies. [9] From an HSA/FSA perspective, brand and generic are treated identically; both are prescription drugs and both are eligible.


How to Get Oral Micronized Progesterone Cheaper

Strategy 1: Generic Substitution

The most immediate savings come from substituting brand Prometrium for a generic. GoodRx and similar platforms list generic micronized progesterone (100 mg, 30 capsules) at $18 to $35 at many pharmacies as of mid-2025. Brand Prometrium at the same dose runs $180 to $280 without insurance. Asking the pharmacist to dispense the generic when you drop off a prescription written simply for "progesterone 100 mg capsules" will trigger substitution automatically at most chains unless the prescriber writes "dispense as written." [10]

Strategy 2: Manufacturer Copay Cards

AbbVie's Access360 program has offered a Prometrium savings card for commercially insured patients. Eligibility, maximum annual benefit, and income thresholds change each year; check the current terms at the manufacturer's patient assistance page or call 1-800-4SOLVAY. Patients on Medicare or Medicaid are federally excluded from manufacturer copay card programs. [11]

Strategy 3: GoodRx, RxSaver, and Discount Clubs

Prescription discount cards are not insurance. They negotiate cash prices with pharmacy benefit managers. GoodRx, RxSaver, and Cost Plus Drugs (Mark Cuban's pharmacy) all offer progesterone at meaningfully reduced prices. Cost Plus Drugs listed generic micronized progesterone 100 mg at under $20 for 30 capsules in 2025. You cannot combine a discount card with insurance or with an HSA card on the same transaction, but you can pay with the discount card and then seek HSA reimbursement by submitting the receipt afterward. [12]

Strategy 4: 90-Day Supply Through Mail Order

Switching to a 90-day mail-order supply typically reduces the per-unit price because most pharmacy benefit managers price 90-day fills at 2.5 times the 30-day copay rather than three times. Over 12 months, that saves roughly the equivalent of one full month's cost. [6]

Strategy 5: Patient Assistance Programs (PAPs)

AbbVie's myAbbVie Assist program provides free medication to uninsured or underinsured patients who meet income criteria (generally at or below 400% of the federal poverty level). The application requires proof of income, proof of no insurance coverage, and a prescriber's signature. Processing typically takes 2 to 4 weeks. [11]

Strategy 6: Telehealth Prescribers and HealthRX

Telehealth HRT platforms often have negotiated cash pricing with compounding or 503B pharmacies, which may substantially cut costs compared with brand Prometrium at a retail chain. HealthRX prescribers can write for FDA-approved generic progesterone or, when clinically indicated, for compounded formulations at pharmacies with which HealthRX has pricing relationships.

The table below compares your realistic 2026 out-of-pocket options for a 30-day continuous regimen of progesterone 100 mg nightly:

| Source | Estimated 30-Day Cost | HSA/FSA Eligible | |---|---|---| | Brand Prometrium, retail | $180, $280 | Yes | | Generic, retail (no discount) | $40, $80 | Yes | | Generic via GoodRx / RxSaver | $18, $35 | Yes (submit receipt) | | Cost Plus Drugs | ~$18, $22 | Yes (submit receipt) | | Mail order (90-day, per-month equivalent) | $15, $28 | Yes | | PAP (eligible patients) | $0 | N/A |


HSA vs. FSA: Key Differences That Affect Your Strategy

Rollover Rules and Timing

HSA balances roll over indefinitely because they are owned by the account holder. FSA balances follow "use it or lose it" rules, though employers may offer a grace period of up to 2.5 months or a $660 rollover provision (2024 IRS limit). If your FSA plan year closes December 31 and you have remaining funds, paying for a 90-day progesterone supply in December is a practical way to use those funds before they lapse. [13]

Contribution Limits for 2025 and 2026

  • HSA (self-only coverage): $4,300 in 2025, expected to adjust for 2026 per IRS Revenue Procedure 2024-25. [13]
  • HSA (family coverage): $8,550 in 2025.
  • FSA: $3,300 in 2025.

Contributing the maximum to an HSA and directing those funds to ongoing HRT costs is a tax-efficient strategy because HSA contributions are pre-tax (or tax-deductible if made outside payroll), growth is tax-free, and withdrawals for eligible medical expenses are also tax-free.

Eligible Plan Requirements

You can only contribute to an HSA if you are enrolled in a High Deductible Health Plan (HDHP). An HDHP in 2025 requires a minimum annual deductible of $1,650 (self-only) or $3,300 (family) and a maximum out-of-pocket limit of $8,300 (self-only). FSAs are available with most traditional employer health plans and do not require an HDHP. [13]


Step-by-Step: Submitting an HSA/FSA Claim for Progesterone

Before You Fill the Prescription

Confirm your plan administrator's preferred documentation format. Some portals require the itemized pharmacy receipt; others accept an Explanation of Benefits from your insurer. A phone call to the number on the back of your card saves time later.

At the Pharmacy

Ask the pharmacist for an itemized receipt that includes:

  • Drug name and strength (e.g., progesterone 100 mg capsules)
  • Quantity dispensed
  • Date filled
  • Prescription number
  • Amount paid

Generic receipts from major chains meet these requirements automatically. Keep the paper and a digital photo of it.

After the Fill

  1. Log into your HSA or FSA portal within 5 business days while the receipt is fresh.
  2. Select "submit new claim" or "request reimbursement."
  3. Upload the receipt image (JPEG or PDF; most portals accept both).
  4. Enter the date of service and amount.
  5. Submit. Most administrators send a decision within 3 to 7 business days. [5]

If Your Claim Is Denied

Denials for prescription medications are uncommon but can occur if the receipt lacks required fields or the administrator flags the drug code as needing additional documentation. In that case, request a Letter of Medical Necessity from your prescriber. The letter should state the diagnosis (e.g., menopausal hormone deficiency, ICD-10 code N95.1) and confirm that progesterone is prescribed for a medical condition. Resubmit with the letter attached. [14]


Safety and Regulatory Background

Oral micronized progesterone is FDA-approved (NDA 019781, original approval 1998) and carries a Pregnancy Category B designation in its original labeling, though prescribers now use the updated Pregnancy and Lactation Labeling Rule framework. [1] The Endocrine Society's 2015 clinical practice guideline on menopausal hormone therapy supports the use of progesterone for endometrial protection in women with an intact uterus receiving estrogen therapy. [15] A 2019 Cochrane review of progestogens for prevention of endometrial hyperplasia (N=4,151 across 28 trials) confirmed that progestogen co-administration significantly reduces hyperplasia risk compared with estrogen alone (relative risk 0.17, 95% CI 0.08 to 0.35, P<0.001). [16]

The drug has a well-characterized adverse effect profile: the most common effects are somnolence (reported in 32.2% of subjects in the key trial vs. 12.7% placebo), dizziness, and breast tenderness, according to the FDA-approved prescribing information. [1] Because progesterone is sedating, the 200 mg dose is typically taken at bedtime. [1]

The Menopause Society recommends that treatment decisions be individualized and that the risks and benefits of hormone therapy be reassessed at least annually. [7] Prescribers at HealthRX follow this guideline; ongoing prescriptions are reviewed each year before renewal.


Frequently asked questions

Can I use my HSA or FSA to pay for oral micronized progesterone?
Yes. Oral micronized progesterone is an FDA-approved prescription drug and qualifies as an eligible expense under both HSAs and FSAs per IRS Publication 502. Pay directly with your HSA/FSA card at the pharmacy or submit the itemized receipt for reimbursement.
Does Prometrium qualify for FSA reimbursement?
Yes. Brand Prometrium and all FDA-approved generic versions of micronized progesterone qualify for FSA reimbursement. Retain the itemized pharmacy receipt showing the drug name, Rx number, date, and amount paid.
Is a Letter of Medical Necessity needed for progesterone HSA claims?
Usually not. Prescription drugs are auto-approved in most HSA and FSA systems. A Letter of Medical Necessity is only needed if the administrator denies the claim and requests additional documentation, which is uncommon for FDA-approved prescription medications.
Can I use HSA funds for compounded progesterone?
Yes, provided the compounded progesterone is dispensed pursuant to a valid prescription at a licensed pharmacy and is not classified as cosmetic. Confirm with your plan administrator before submitting, as some administrators request additional documentation for compounded drugs.
How do I get oral micronized progesterone cheaper without insurance?
The most effective strategies are: (1) request the generic instead of brand Prometrium, (2) use GoodRx or Cost Plus Drugs for cash pricing as low as $18 per 30-day supply, (3) apply for AbbVie's myAbbVie Assist PAP if you meet income criteria, and (4) switch to a 90-day mail-order supply to reduce per-unit cost.
Is there a Prometrium manufacturer discount card?
AbbVie has offered an Access360 savings card for commercially insured patients. Terms and eligibility change annually. Medicare and Medicaid patients are federally excluded. Check the current program at the AbbVie Access360 website or call 1-800-4SOLVAY.
What is the difference between Prometrium and generic micronized progesterone for HSA purposes?
There is no difference for HSA or FSA purposes. Both are prescription drugs and both qualify as eligible expenses. The generic typically costs 75-90% less than brand Prometrium at retail.
Can I use my FSA for progesterone prescribed through telehealth?
Yes. Telehealth prescriptions issued by state-licensed clinicians are treated the same as in-person prescriptions for HSA and FSA purposes, provided the prescription is dispensed by a licensed pharmacy.
Does progesterone prescribed for menopause qualify as an eligible HSA expense?
Yes. The IRS does not restrict eligible drug expenses by the indication. Any FDA-approved prescription drug dispensed by a licensed pharmacist qualifies, including progesterone prescribed for menopausal hormone therapy.
What documentation do I need to submit a progesterone FSA claim?
You need an itemized pharmacy receipt showing the drug name, strength, quantity, date dispensed, Rx number, and amount paid. Some administrators also accept an Explanation of Benefits from your insurer.
Can I pay for a 90-day progesterone supply with my FSA before the plan year ends?
Generally yes. FSAs allow you to pay for expenses incurred during the plan year, which includes filling a 90-day supply within that year. Prepaying for the next plan year's supply is typically not allowed; the drug must be dispensed, not just ordered.
Is progesterone covered by Medicare Part D?
Micronized progesterone is on most Medicare Part D formularies, though tier placement and copay vary by plan. Check your specific plan's formulary at medicare.gov. Note that Medicare patients cannot use manufacturer copay cards.

References

  1. U.S. Food and Drug Administration. Prometrium (progesterone) prescribing information. NDA 019781. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019781s023lbl.pdf

  2. Internal Revenue Service. Publication 502: Medical and Dental Expenses. 2024 edition. https://www.irs.gov/pub/irs-pdf/p502.pdf

  3. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

  4. National Institutes of Health, National Library of Medicine. Health Savings Accounts and health care utilization. Health Serv Res. 2014;49(4):1405 to 1420. https://pubmed.ncbi.nlm.nih.gov/24628452/

  5. HealthEquity. HSA reimbursement guide. https://www.healthequity.com/learn/hsa

  6. Doshi JA, et al. Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents. J Clin Oncol. 2018;36(5):476 to 482. https://pubmed.ncbi.nlm.nih.gov/29232173/

  7. The Menopause Society. The 2023 Menopause Society position statement on hormone therapy. Menopause. 2023;30(6):573 to 590. https://pubmed.ncbi.nlm.nih.gov/37252752/

  8. Harman SM, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 2005;8(1):3 to 12. https://pubmed.ncbi.nlm.nih.gov/15804727/

  9. U.S. Food and Drug Administration. Abbreviated New Drug Applications (ANDAs): Generic drugs. https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda

  10. Socal MP, et al. Favorable prices for generic drugs in 5 large US pharmacies: implications for physician counseling. JAMA Intern Med. 2019;179(5):732 to 734. https://pubmed.ncbi.nlm.nih.gov/30830157/

  11. AbbVie. MyAbbVie Assist patient assistance program. https://www.abbvie.com/patients/patient-assistance.html

  12. Kesselheim AS, et al. Variations in drug prices at pharmacies in the United States. N Engl J Med. 2016;375:1600 to 1602. https://pubmed.ncbi.nlm.nih.gov/27797314/

  13. Internal Revenue Service. Revenue Procedure 2024-25: HSA inflation adjustments for 2025. https://www.irs.gov/pub/irs-drop/rp-24-25.pdf

  14. Centers for Disease Control and Prevention. ICD-10-CM code N95.1: Menopausal and female climacteric states. https://www.cdc.gov/nchs/icd/icd10cm_browsertool.htm

  15. Stuenkel CA, et al. Treatment of symptoms of the menopause: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975 to 4011. https://pubmed.ncbi.nlm.nih.gov/26444994/

  16. Furness S, et al. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev. 2012;8:CD000402. https://pubmed.ncbi.nlm.nih.gov/22895916/

Free2-min check·
Start assessment